Mesa Laboratories, Inc.MLABNASDAQ

Revenue (LTM)

$241M

+11.5% YoY

Net Income (LTM)

$-2M

+99.2% YoY

Free Cash Flow

$42M

Revenue CAGR (5Y)

+15.4%

—Marginsstable

FCF$0.0B

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	134	184↑37.6%	219↑18.8%	216↓1.3%	241↑11.5%
Gross Profit	87	109↑25.4%	134↑22.6%	133↓0.3%	151↑13.2%
Operating Income	12	5↓62.0%	3↓29.4%	-272↓8295.0%	16↑106.0%
Net Income	3	2↓42.9%	1↓50.3%	-254↓27438.3%	-2↑99.2%
EBITDA	28	33↑16.2%	38↑15.3%	-238↓735.4%	42↑117.8%
EPS Diluted	0.64	0.35↓45.3%	0.17↓51.4%	-47.20↓27864.7%	-0.36↑99.2%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	264	49↓81.3%	33↓33.3%	28↓14.3%	27↓3.2%
Total Current Assets	304	124↓59.1%	119↓4.3%	109↓8.1%	103↓6.1%
Total Assets	601	707↑17.6%	662↓6.4%	447↓32.5%	433↓3.0%
Total Current Liabilities	33	48↑47.5%	43↓9.8%	44↑2.2%	164↑270.0%
Total Liabilities	195	314↑60.6%	268↓14.4%	301↑12.3%	274↓9.3%
Total Equity	406	394↓3.1%	393↓0.1%	145↓63.0%	160↑9.9%
Total Debt	147	221↑50.7%	186↓15.8%	231↑24.3%	181↓21.5%
Net Debt	-117	172↑246.6%	153↓10.8%	203↑32.5%	154↓24.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	37	39↑5.8%	28↓28.7%	44↑57.7%	47↑6.1%
Capital Expenditure	-2	-4↓122.5%	-5↓2.5%	-3↑43.5%	-4↓75.3%
Free Cash Flow	35	35↓0.8%	23↓32.6%	42↑77.3%	42↑1.8%
Stock-Based Comp	9	11↑22.9%	13↑10.1%	12↓4.8%	13↑10.1%
Net Change in Cash	182	-215↓217.6%	-16↑92.3%	-5↑71.4%	-1↑81.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance